Scholarlink

<p>The MAPK signaling pathway plays a considerable role in cancer inhibition, and pyroptosis is a type of programmed cell death (PCD); thus, it is essential for cellular activity and cancer progression. Juglone can inhibit the viability and motility of cancer cells, but it is unclear whether it can induce pyroptosis in cancer cells, and the corresponding regulatory mechanisms are not well understood. This study explored the in vitro effects of juglone on OS cells, further revealing its ability to induce pyroptosis via the caspase-3/GSDME pathway. Moreover, juglone can regulate the GSDME pathway to induce both pyroptosis and apoptosis through the JNK/p38 pathway. These findings suggest that juglone has potential as a therapeutic agent for osteosarcoma.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Juglone induces GSDME axis pyroptosis in osteosarcoma cells via the JNK/P38 MAPK pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月23日

查看全文
  • Jierui Zhao,
  • Xingyu Zhao,
  • Yue Lu,
  • He Wang,
  • Yuhan Zhang,
  • Yi Wang,
  • LiChun Xing,
  • Yumiao Guo,
  • Peng Peng,
  • Wei Zhang,
  • Qibiao Wu

摘要

The MAPK signaling pathway plays a considerable role in cancer inhibition, and pyroptosis is a type of programmed cell death (PCD); thus, it is essential for cellular activity and cancer progression. Juglone can inhibit the viability and motility of cancer cells, but it is unclear whether it can induce pyroptosis in cancer cells, and the corresponding regulatory mechanisms are not well understood. This study explored the in vitro effects of juglone on OS cells, further revealing its ability to induce pyroptosis via the caspase-3/GSDME pathway. Moreover, juglone can regulate the GSDME pathway to induce both pyroptosis and apoptosis through the JNK/p38 pathway. These findings suggest that juglone has potential as a therapeutic agent for osteosarcoma.